Navigation Links
Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services

SWARTZ CREEK, Mich., April 8, 2008 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced Mike Maynard has joined the company as Director of National Accounts. Maynard reports directly to Dr. Atheer Kaddis, Vice President of Managed Markets.

Maynard is responsible for the development and national expansion of Diplomat's disease management programs, focusing initially on chronic kidney disease, dialysis, and renal transplant. Diplomat's disease management programs, through direct patient contact and coordination with physicians, improve access, tolerance, and compliance to appropriate medication therapy resulting in improved patient outcomes.

"Diplomat Specialty Pharmacy is very excited to welcome Mike Maynard to our team," said Kaddis. "He will lead our efforts in working with providers, employer groups and managed care organizations to further expand our best in class disease management programs focusing on chronic kidney disease, dialysis, and renal transplant. Mike will help Diplomat become a national leader in caring for patients with kidney disease."

"After spending many years in the renal marketplace, I am very excited to join the team at Diplomat Specialty Pharmacy," said Maynard. "Disease Management programs and initiatives can stem progression of disease, improve medication adherence, control costs and improve quality of life. Diplomat's CKD Navigator Program, as well as the Dialysis and Transplant Programs, are the most comprehensive and innovative programs available. I look forward to being a part of the great things that are happening at Diplomat Specialty Pharmacy."

Maynard's fifteen years as an executive in the pharmaceutical industry include extensive experience in sales, sales management and training, and Regional and National Account Management. Immediately before joining Diplomat Specialty Pharmacy, he served as an Integrated Delivery Network/Renal Account Manager with Roche Pharmaceuticals. In addition, he has over eight years of experience in the renal marketplace with Sigma-Tau Pharmaceuticals, and brings extensive experience in contract negotiation, and developing and implementing sales/marketing strategies with dialysis providers and renal Group Purchasing Organizations. Maynard holds a Bachelor of Business Administration degree from Western Michigan University, Kalamazoo, MI.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns


SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
2. American Specialty Health and INSPIRIS Win Top Honors in URACs Best Practices in Consumer Empowerment and Protection Awards
3. Zero Patient Infections Reported as D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals
4. EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
5. MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative
6. Specialty Underwriters Alliance, Inc. Reports 2007 Fourth Quarter and Full Year Results
7. Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailers Prospects for 2008
8. Specialty European Pharma launches plenaxis in Germany
9. Darwin Enters into Marketing Partnership with Agency Specialty Product Network
10. Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
11. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday ... dish and pleasing the palates of attendees is of the utmost importance. Whether ... a seasonal get-together, give these recipes a try this holiday season. , Turkey ...
(Date:11/25/2015)... Nairobi (PRWEB) , ... November 26, 2015 , ... ... African Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, ... Nations Office in Nairobi (UNON) for the opening of the 5th African Network ...
(Date:11/25/2015)... ... 25, 2015 , ... Dental professionals who would like to become more proficient ... attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held ... the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud ...
(Date:11/25/2015)... ... 2015 , ... Smiles by Stevens is pleased to announce the ... While many patients are aware of the benefits of Botox® in the treatment of ... suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a ... “I thought there had to be a convenient and comfortable way to protect them ... enables disabled individuals to safely travel during cold or inclement weather. In doing so, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- ) has announced the ... Viscosity Drugs" report to their offering. ... of the "Self Administration of High Viscosity ... Research and Markets ( ) has ... of High Viscosity Drugs" report to their ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: